These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 145543)

  • 1. Long term culture of tumour-specific cytotoxic T cells.
    Gillis S; Smith KA
    Nature; 1977 Jul; 268(5616):154-6. PubMed ID: 145543
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
    Gillis S; Smith KA
    J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse].
    Jezzi T; Premrov MG; Del Gobbo V; Garaci E
    Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of the mechanisms for the induction of in vivo tumor immunity. I. Induction of primary and secondary cell-mediated cytotoxic responses by adoptive transfer of lymphocytes.
    Ting CC
    Cell Immunol; 1976 Nov; 27(1):71-81. PubMed ID: 136303
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.
    Chesebro B; Wehrly K
    J Exp Med; 1976 Jan; 143(1):85-99. PubMed ID: 1081583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the mechanisms for the induction of in vivo tumor immunity. II. Distribution and homing of cytotoxic effector and precursor cells.
    Ting CC
    J Natl Cancer Inst; 1978 Feb; 60(2):437-44. PubMed ID: 304488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on cell surface antigens of mouse leukemic and normal lymphocytes. IV. Functional studies on mouse T lymphocyte subpopulations. A. Culture conditions for generation of cytotoxic T lymphocytes.
    Kuśnierczyk P; Wysocka M; Kisielow P; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):105-10. PubMed ID: 155432
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor neutralization, immunotherapy, and chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: II. Comparison of cells cultured with and without tumor to noncultured immune cells.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1978 Dec; 121(6):2220-7. PubMed ID: 152790
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro depression of cellular immunity by Friend virus leukemic spleen cells.
    Toy ST; Whellock EF
    Cell Immunol; 1975 May; 17(1):57-73. PubMed ID: 1168547
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Friend virus-induced immunodepression: effect of neuraminidase treatment on Thy-1.2 antigen expression and cytotoxic potential of splenocytes from virus-infected mice.
    Mascio AA; Ceglowski WS
    Infect Immun; 1978 Feb; 19(2):486-92. PubMed ID: 305416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections.
    Genovesi EV; Marx PA; Wheelock EF
    J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.
    Kumar V; Caruso T; Bennett M
    J Exp Med; 1976 Apr; 143(4):728-40. PubMed ID: 1082914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity.
    Ting CC; Rodrigues D; Igarashi T
    J Immunol; 1979 Apr; 122(4):1510-8. PubMed ID: 221575
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of T cell-mediated immunity by tumor cells: immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors.
    Ting CC; Rodrigues D; Ting RC; Wivel N; Collins MJ
    Int J Cancer; 1979 Nov; 24(5):644-55. PubMed ID: 160896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity.
    Blank KJ; Lilly F
    Nature; 1977 Oct; 269(5631):808-9. PubMed ID: 73137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.